Silverarc Capital Management »

Unicycive Therapeutics shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Unicycive Therapeutics

23:59:59.999Sep 29, 202423:59:59.999500:00:00Sep 30, 202400:00:00.000500:00:00.0011.631599M1.6315995M1.6316M1.6316005M1.631601M3.999999M3.9999995M4M4.0000005M4.000001M
Value ($)Share countHistorical UNCY position of Silverarc Capital Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.6M 4.0M 0.41

More positions owned by Silverarc Capital Management

Nuvalent Inc-a (NUVL)
Merus N V (MRUS)
Insmed Com Par $.01 (INSM)
Avidity Biosciences Ord (RNA)
Erasca (ERAS)
Akero Therapeutics (AKRO)
Veracyte (VCYT)
Rhythm Pharmaceuticals (RYTM)
Cogent Biosciences (COGT)
Intra Cellular Therapies (ITCI)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Urogen Pharma (URGN)
Oric Pharmaceuticals (ORIC)
Poseida Therapeutics I (PSTX)
Verona Pharma Sponsored Ads (VRNA)

View all positions for Silverarc Capital Management

Top funds holding Unicycive Therapeutics

Dr. Jeffrey R. Jay, M.D.
Nantahala Capital Management
Octagon Capital Advisors
Vivo Capital
Logos Global Management
Walleye Trading Advisors
Silverarc Capital Management
Longwood Capital Partners
Alyeska Investment Group
Altium Capital Management
Vanguard Group
Geode Capital Management
XTX Topco
State Street Corporation
Goldman Sachs Group

View all funds holding Unicycive Therapeutics